Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

October 04, 2015 6:35 PM ET

Healthcare Equipment and Supplies

Company Overview of Aspire Bariatrics, Inc.

Company Overview

Aspire Bariatrics, Inc. develops and commercializes weight loss solutions for customers in Europe and internationally. It offers AspireAssist, a weight loss solution for people with obesity. Its AspireAssist works by reducing the calories absorbed by the body. Aspire Bariatrics, Inc. was formerly known as Aspiration Medical Technology, LLC. The company was incorporated in 2004 and is based in King Of Prussia, Pennsylvania.

3200 Horizon Drive

Suite 100

King of Prussia, PA 19406

United States

Founded in 2004





Key Executives for Aspire Bariatrics, Inc.

Chairman of The Board, Chief Executive Officer and President
Age: 65
Founder and Director
Founder and Director
Executive Vice President of Sales, Marketing and Clinical Support
Compensation as of Fiscal Year 2015.

Aspire Bariatrics, Inc. Key Developments

Aspire Bariatrics Inc. Secures $12 Million Venture Loan Facility with Hercules Technology Growth Capital

Aspire Bariatrics Inc. announced that it has closed on up to $12 million in venture debt financing with Hercules Technology Growth Capital. The financing will support the continuation of the company's PATHWAY pivotal trial in the US and Pre-Market Application filing, expected in mid-2015. The financing will also support ongoing post-market studies for the device, which is currently approved for commercial sale in Europe.

Aspire Bariatrics, Inc. Announces Completion of Enrollment & Device Implantation in Pivotal US Trial

Aspire Bariatrics, Inc. announced that it has completed enrollment and device implantation in the company's PATHWAY pivotal trial for obesity as of June 18, 2014. A total of 171 patients have been enrolled at 10 clinical sites in the United States. The PATHWAY trial is a randomized, controlled, pivotal study testing the effectiveness and safety of the AspireAssist Aspiration Therapy System in the treatment of obesity in patients with initial body mass index from 35.0-55.0 kg/m. The AspireAssist is a first in class chronic weight loss treatment which is designed to reduce caloric absorption while gradually changing eating habits. The device does not alter the patient's gastrointestinal anatomy, is minimally invasive, and is easily reversible. The company also announced the initiation of post-market studies in Italy, United Kingdom, Austria, and Germany, in addition to ongoing post-market studies in Sweden, Czech Republic, and Spain.

Similar Private Companies By Industry

Company Name Region
Yawa-Med, Inc. United States
Accriva Diagnostics United States
Aqueous Biomedical, Inc. United States
Wiley X, Inc. United States
Zynex Medical, Inc. United States

Recent Private Companies Transactions

Private Placement
January 29, 2015

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Aspire Bariatrics, Inc., please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at